Tag Archives: approves

[ad_1] A new migraine drug is entering an already crowded market, but it could mean fewer headaches for some patients. The pharmaceutical group Eli Lilly announced Thursday that the FDA had approved …

[ad_1] In this photo from December 9, 2015, sales representative Mike Conway, right, shows a pistol to Paul Angulo at the Bullseye Sport Weapons Store in Riverside, California. Governor Jerry Brown has …

[ad_1] A new migraine drug is entering an already crowded market, but it could mean fewer headaches for some patients. The pharmaceutical group Eli Lilly announced Thursday that the FDA had approved …

[ad_1] Governor Jerry Brown has signed two bills that could make Internet-connected device makers more accountable for protecting the privacy and safety of California residents. On September 28, the governor's office announced …

[ad_1] The US Food and Drug Administration today approved a new drug, Arikayce (suspension of amikacin liposome inhalation), to treat a lung disease caused by a group of bacteria Mycobacterium avium complex …

[ad_1] WASHINGTON – The FDA has approved the inhalation suspension of insamed amikacin liposomes (Arikayce) for a limited population of patients with some type of non-tuberculous mycobacterial lung infection, said the agency …

[ad_1] FDA approves use of Eisai (OTCPK: ESALY + 1.8%) FYCOMPA (perampanel) CIII, alone or in combination with other medicinal products, for the treatment of pediatric patients with partial seizures and at …

[ad_1] The FDA has approved Emgality, a subcutaneous injection, once a month, self-administered, for the preventive treatment of migraine in adults, according to a press release issued by the manufacturer. "Despite the …

[ad_1] September 28, 2018 – The FDA has approved the third of a new type of medication to prevent migraine headaches in adults. Galcanezumab-gnlm (Emgalité) targets the calcitonin gene-related peptide (CGRP), a …

[ad_1] The Food and Drug Administration has approved the injection of Eli Lilly (NYSE: LLY) for the preventive treatment of migraine in adults, one of three drugs in a new class recently …